Allay Therapeutics Announces Development and Commercialization Agreement With Maruishi Pharmaceutical

Palo Alto – December 18, 2023 – Cooley advised Allay Therapeutics, a pioneer in a new category of ultra-sustained pain therapeutics to transform post-surgical pain management and recuperation for patients and physicians, on its license agreement to provide Maruishi Pharmaceutical with exclusive rights in Japan to develop and commercialize Allay’s lead investigation drug candidate – ATX101 – and other ultra-sustained analgesic implantable drug candidates for acute pain. Lawyers Mark Weeks, Lila Hope, Alex Kassai, Mike Perretta and Zack Gong led the Cooley team advising Allay.

Under the terms of the agreement, Allay will receive an upfront payment and equity investment from Maruishi. Allay also is eligible to receive future milestone payments related to predefined clinical and regulatory events in the US and Japan, as well as commercial milestones and royalties on sales in Japan. Allay retains the right to develop and commercialize ATX101 in all territories outside Japan.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has more than 1,300 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of nearly 3,000.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.